Since I am the one who is undergoing SCS, I have dug deeper into the subject. Of interest to me is the AI aspect of the device being used in conjunction with SCS, the HFX, and research studies about the efficacy of such treatment. In the blog, I will first present more complete information about the former, and embed three research papers concerning the Efficacy of such treatment.
More on the AI aspect:
The HFX device is a spinal cord stimulation (SCS) system that uses advanced artificial intelligence (AI) technology to deliver personalized pain relief to patients with chronic pain. It was developed by Nevro and is known as HFX iQ or HFX AdaptivAI in its advanced form.
How the AI in the HFX Device Works
- The system integrates high-frequency (10 kHz) spinal cord stimulation therapy with AI algorithms built on extensive clinical data—over 20 million data points from 80,000 implanted patients—to optimize individualized therapy programs for pain relief.
- AI analyzes patient inputs such as daily pain levels, medication usage, activity changes, and quality of life factors through a companion smartphone app.
- Based on this data, it provides personalized, real-time therapy recommendations and adjustments to maintain or improve pain relief over time.
- The system uses Bipole Interlacingâ„¢ technology that creates custom therapy programs dynamically.
- It also features Smart Power technology to reduce the frequency of device charging to as little as six times per year.
- The AI is designed to optimize therapy responsiveness by learning from the patient’s unique pain experience and evolving their treatment accordingly, accelerating relief and improving quality of life.
- Advanced remote monitoring allows physicians to access real-time data on the patient’s pain journey, device status, and therapy effectiveness, enabling proactive clinical intervention.
What the Device Does for Patients
- It provides continuous, personalized pain relief by blocking or quieting the pain signals at the source in the spinal cord before they reach the brain.
- Patients can engage easily with the system via the smartphone app, reporting pain and lifestyle data, thus empowering them in their pain management.
- The AI system helps to reduce unnecessary hospital visits by enabling remote adjustments and monitoring.
- It addresses multiple chronic pain types, including back and leg pain, painful diabetic neuropathy, non-surgical refractory back pain, and upper limb/neck pain.
- The therapy offers a wider frequency range than many other SCS systems, helping patients maintain effective pain relief long term.
- Clinical studies and real-world data support its efficacy, showing faster and sustained pain relief with improved patient quality of life.
Nevro’s HFX iQ with AI technology represents a transformative advancement in spinal cord stimulation therapy by combining robust clinical evidence with intelligent, data-driven, and patient-centered pain management.
And now three research papers:
Leave a Reply